With no major domestic economic data due today, European developments and U.S. company earnings are likely to be in the spotlight. Concerns over growth were highlighted this morning when the German IFO Index, which measures business confidence, came in lower for the fifth consecutive month, falling from 102.3 to 101.4 in September.
Concerns are also growing that many U.S. companies will begin reporting weaker earnings over the next half-year. No major companies are reporting today, but homebuilder Lennar got the day off to a good start, reporting earnings of $0.40 per share on revenue of $1.1 billion, beating analysts' expectations for EPS of $0.28 on revenue of $1.02 billion. Due to report after the bell tonight are PayChex and Red Hat.
European markets fell this morning, thanks to the disappointing German business confidence reading and fears that progress on fixing the eurozone crisis may be stalling. Spanish 10-year bond yields rose to 5.8% as investors continue to question how long beleaguered Prime Minister Mariano Rajoy will resist before requesting a bailout.
At 7 a.m. EDT, the DAX was down 0.7%, the CAC was down 1.2%, the FTSE MIB was down 1.4%, and the IBEX was down 1.5%. In London, the FTSE 100 (FTSEINDICES:^FTSE) was down by 0.6%, with miners continuing their rollercoaster ride and giving up recent gains once more. At 7 a.m. EDT, the six biggest losers were all mining shares, led by Evraz and ENRC, both of which were down more than 4%. Heading the other way were defensive favorites GlaxoSmithKline and Centrica: Both stocks were up by around 0.5% at the end of the morning sessions.
Billionaire investor Warren Buffett rarely invests outside the U.S., but he did recently invest $1 billion in another well-known British blue-chip brand, expanding his stake in the company to more than 5%. The business concerned is a famous British name with global expansion potential -- and you can discover the identity of the company and the price he paid in this special exclusive report. Best of all, the report is free -- so download it today while it's still available.
Are you looking to profit from this uncertain economy? "10 Steps To Making A Million In The Market" is The Motley Fool's latest report. We urge you to read it today -- your wealth could be transformed. Click here now to request your free, no-obligation copy. The Motley Fool is helping Britain invest. Better.
Further investment opportunities:
Roland Head owns shares in GlaxoSmithKline but has no shares in any of the other companies mentioned in this article. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
Starbucks Corporation Lowered Its Expectations. Will It Meet Them?
Last quarter, Starbucks backed off on its goals for revenue and profit growth. Here's what to expect when it reports its results next week.
Kohl's Takes the Retail Crown After a Busy Holiday Season
Retail trends improved dramatically during the holiday months compared to the rest of 2017, lifting many department stores out of their recent sales funk.
Is It Game Over for Medical Marijuana in Colorado?
Medical marijuana demand is waning.